New York County Jail Runs $866,000 Short on Opioid Treatment Funding

St. Lawrence County budgeted $866,243 for medication-assisted treatment in its jail this year. The state sent $160,000. The $706,243 gap is not a bookkeeping error. It is the difference between what New York requires counties to provide and what Albany actually pays for.

The county's Opioid Treatment Program, which serves residents both inside and outside the jail, is now running at a $578,690 deficit according to figures reported August 19. Meanwhile, the jail's total 2026 appropriations hit $10.4 million, an 11.4 percent increase over last year's budget. State aid for the mandated MAT program did not keep pace.

This is not a new complaint. In 2023, then-Sheriff Brooks Bigwarfe warned legislators that the MAT program would likely cost over $800,000 annually while the county had received roughly $100,000 to offset it. Three years later, the ratio has barely shifted.

---

The Clinical Case for Jail MAT

Medication-assisted treatment in correctional settings is not optional for counties. New York mandates it. The clinical reasoning is straightforward and well-documented.

Opioid withdrawal in custody is a medical event with life-or-death stakes. Forced abstinence during incarceration drives tolerance down sharply. When someone returns to their previous dose after release, the risk of fatal overdose is at its highest point. The weeks following jail discharge are among the most dangerous in an opioid user's life.

Continuing or starting buprenorphine or methadone during incarceration keeps tolerance stable, treats withdrawal, and links people to community treatment on release. The alternative—detox without medication, followed by discharge with no continuity of care—creates the conditions for overdose deaths.

St. Lawrence County's jail, like every county jail in New York, operates under this mandate. The requirement does not fund itself.

---

Where the Money Goes

The $866,243 budget line covers medications, medical supervision, counseling, and administrative costs tied to providing MAT in custody. Buprenorphine and methadone require licensed providers. Extended-release injectable buprenorphine, increasingly favored in correctional settings because it removes daily dosing requirements, is not cheap.

The $160,000 state aid figure reported this month covers both the jail MAT program and the county's Opioid Treatment Program combined. Jail grants contributed zero dollars for the sixth consecutive year. County legislators describe the programs as unfunded mandates absorbed by local taxpayers.

The funding shortfall creates pressure points throughout the system. Counties can backfill the gap from general funds, trim services, or redirect opioid settlement dollars intended for program expansion into basic compliance. None of these choices expand access. They merely maintain it at current levels while draining other budget lines.

---

The Three Medications

New York's jail MAT mandate covers three FDA-approved medications, each with distinct clinical profiles and cost structures.

Methadone is a full opioid agonist dispensed through licensed opioid treatment programs under strict federal regulation. It prevents withdrawal and reduces cravings but requires daily supervised dosing and careful titration during induction. The infrastructure for methadone—nursing staff, security protocols, licensure compliance—drives costs up.

Buprenorphine is a partial agonist with a ceiling effect that limits respiratory depression. It is available in daily sublingual tablets or films and in extended-release monthly injections. The injectable form has become attractive to correctional facilities because it removes daily dosing logistics and reduces diversion risk. The tradeoff is higher medication cost upfront.

Naltrexone is an opioid antagonist that blocks opioid effects without causing physical dependence. It must be started only after full detoxification, since giving it too early accelerates withdrawal. That sequencing requirement makes naltrexone unsuitable for withdrawal management in jail, though it can work for stable patients preparing for release.

All three reduce overdose mortality. None are interchangeable for every patient. The right medication depends on the person's history, clinical status, and post-release plans. Providing all three options costs more than providing one.

---

The Broader Pattern

St. Lawrence County is not unique. County jails across upstate New York face similar gaps between state mandates and state aid. The pattern is familiar: Albany passes a requirement, funds it partially or not at all, and leaves counties to absorb the cost or face noncompliance.

The opioid settlement funds—New York's share of national litigation against pharmaceutical manufacturers—were supposed to expand treatment capacity, not backfill existing mandates. Yet county budgets show settlement dollars increasingly flowing toward basic operational costs rather than new services.

For someone entering a St. Lawrence County jail in opioid withdrawal, the budget line is not abstract. It determines whether a physician evaluates them within hours or days, whether medication is started immediately or delayed, and whether anyone arranges care for the day they walk out. The $706,243 gap has a human dimension measured in withdrawal severity, overdose risk, and mortality statistics.

---

What Happens Now

County officials have raised these issues since at least 2023 with no resolution from Albany. The 2026 budget figures suggest the gap is widening, not closing. State aid has not kept pace with either program costs or jail population needs.

The county legislature will face the same choices next budget cycle: raise local taxes to fund a state mandate, cut other services, or scale back MAT availability. None of these options improve outcomes for people in custody.

New York's requirement that jails provide medication-assisted treatment is sound policy grounded in overdose prevention evidence. The funding mechanism that leaves counties hundreds of thousands of dollars short is not.

For information on accessing MAT services in New York, SAMHSA's National Helpline at 1-800-662-4357 provides free, confidential referrals 24 hours daily.